Literature DB >> 24589281

Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance.

Barry J Maron1, Tammy S Haas2, Martin S Maron3, John R Lesser2, Joseph A Browning2, Raymond H Chan4, Iacopo Olivotto5, Ross F Garberich2, Robert S Schwartz2.   

Abstract

In hypertrophic cardiomyopathy (HC), atrial fibrillation (AF) is an important determinant of clinical deterioration due to heart failure or embolic stroke. This study characterizes left atrial (LA) structural and functional parameters to establish markers predictive of AF risk, using cardiovascular magnetic resonance (CMR) imaging. We studied 427 consecutive patients with HC in sinus rhythm with CMR (age 44±18 years), including 41 who developed clinically overt AF after study entry (2.6±2.1 years), 49 patients with AF before CMR, 337 patients with HC but without AF, and 244 normal controls. LA chamber was assessed for absolute and indexed end-diastolic volume (LAEDV), end-systolic volume, and percent ejection fraction (LAEF). In the 41 prospectively studied patients with HC who developed AF during follow-up, LAEDV was significantly greater than in patients without AF (146±48 vs 107±37 ml) or in normal controls (81±24 ml, p<0.001). Percent LAEF was lower in patients developing AF (36±10%) than without AF (46±12%) or controls (55±9%, p<0.001). Multivariate analysis identified LAEF (<38%), LAEDV (≥118 ml), and age (≥40 years) as independently associated with AF occurrence. In conclusion, CMR measures of LA remodeling and dysfunction reliably identified patients with HC at risk for future development of AF. Decrease in LAEF represents a strong novel marker of susceptibility to AF in this disease.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24589281     DOI: 10.1016/j.amjcard.2013.12.045

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  38 in total

Review 1.  Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy.

Authors:  Waseem Hindieh; Raymond Chan; Harry Rakowski
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

2.  Atrial Fibrillation and Anticoagulation in Hypertrophic Cardiomyopathy.

Authors:  C Fielder Camm; A John Camm
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-06

3.  Clinical and echocardiographic parameters as risk factors for atrial fibrillation in patients with hypertrophic cardiomyopathy.

Authors:  Mariusz Klopotowski; Aleksandra Kwapiszewska; Krzysztof Kukula; Jacek Jamiolkowski; Maciej Dabrowski; Pawel Derejko; Artur Oreziak; Rafal Baranowski; Mateusz Spiewak; Magdalena Marczak; Anna Klisiewicz; Barbara Szepietowska; Zbigniew Chmielak; Adam Witkowski
Journal:  Clin Cardiol       Date:  2018-10-16       Impact factor: 2.882

Review 4.  Evaluation of Hypertrophic Cardiomyopathy: Newer Echo and MRI Approaches.

Authors:  Manhal Habib; Sara Hoss; Harry Rakowski
Journal:  Curr Cardiol Rep       Date:  2019-06-26       Impact factor: 2.931

Review 5.  The role of echocardiography in hypertrophic cardiomyopathy.

Authors:  Lynne K Williams; Christiane H Gruner; Harry Rakowski
Journal:  Curr Cardiol Rep       Date:  2015-02       Impact factor: 2.931

6.  Electromechanical dissociation of left atrium in patients with Cardiac Amyloidosis by Magnetic Resonance: Prognostic and clinical correlates.

Authors:  Giovanni Donato Aquaro; Sofia Morini; Chrysanthos Grigoratos; Giulia Taborchi; Gianluca Di Bella; Raffaele Martone; Elisa Vignini; Michele Emdin; Iacopo Olivotto; Federico Perfetto; Francesco Cappelli
Journal:  Int J Cardiol Heart Vasc       Date:  2020-09-14

Review 7.  Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical impact, and management.

Authors:  Lohit Garg; Manasvi Gupta; Syed Rafay Ali Sabzwari; Sahil Agrawal; Manyoo Agarwal; Talha Nazir; Jeffrey Gordon; Babak Bozorgnia; Matthew W Martinez
Journal:  Heart Fail Rev       Date:  2019-03       Impact factor: 4.214

8.  Incidence of Atrial Fibrillation following Alcohol Septal Ablation for Hypertrophic Cardiomyopathy.

Authors:  Travis J Moss; Matthew M Zipse; Mori J Krantz; William H Sauer; Ernesto E Salcedo; Joseph L Schuller
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-03-11       Impact factor: 1.468

Review 9.  Predictors of Atrial Fibrillation Risk in Hypertrophic Cardiomyopathy.

Authors:  Kamil Tuluce; Selcen Yakar Tuluce
Journal:  J Atr Fibrillation       Date:  2015-02-28

Review 10.  Update on hypertrophic cardiomyopathy and a guide to the guidelines.

Authors:  Srijita Sen-Chowdhry; Daniel Jacoby; James C Moon; William J McKenna
Journal:  Nat Rev Cardiol       Date:  2016-09-29       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.